Shanghai Hengrui Pharmaceutical Co., Ltd.
59
26
30
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.1%
3 terminated/withdrawn out of 59 trials
83.3%
-3.2% vs industry average
10%
6 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (59)
A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Role: lead
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Role: lead
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Role: lead
A Phase I Study of SHR-3836 in Patients With Multiple Myeloma
Role: lead
A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism
Role: lead
A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
Role: lead
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Role: lead
Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status
Role: collaborator
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Role: lead
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Role: lead
A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
Role: lead
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
Role: lead
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Role: lead
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Role: lead
The Trial of SHR6508 in Secondary Hyperparathyroidism
Role: lead
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Role: lead
Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
Role: lead
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors
Role: lead
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
Role: lead
A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors
Role: lead